Laurie McGinley

• Health

The vote by the agency’s outside experts increased the likelihood that a contraceptive called Opill will be approved for sale without a prescription.

• Health

For the first time, the Food and Drug Administration is weighing whether to allow a daily contraceptive to be sold over the counter.

• Health

The drug, donanemab, is the latest treatment to target amyloid beta, a protein that builds up in the brain and is a signature characteristic of Alzheimer’s.

• Health

For years, doctors and patients thought there was little to do when dementia was diagnosed, even at an early stage. Now, potentially sweeping changes loom.

• Health

The National Institutes of Health has not had a permanent director since December 2021, when its longtime leader stepped down.

• Health

The shots would be available for people who are at least 65 years old or immune-compromised.

• Health

Texas judge ignored scientific evidence of abortion pill’s safety, citing statistics that overstate the negative physical and psychological effects of mifepristone.

• White House

The Biden administration seeks to reassure abortion rights supporters without running afoul of the courts after conflicting rulings on mifepristone.

• Health

"This opens the door to the courts’ second-guessing any FDA approval — especially for drugs for controversial areas like gender-affirming care," expert says.